| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5553252 | Biomedicine & Pharmacotherapy | 2017 | 8 Pages |
Abstract
We conclude that RGD modified and PEGylated SLN are promising candidate delivery vehicles for cardioprotective drugs in treatment of myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zhaoqiang Dong, Jing Guo, Xiaowei Xing, Xuguang Zhang, Yimeng Du, Qinghua Lu,